Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Sequencing
VieCure, Labcorp collaborate on clinical workflows, genomic testing
The firms are aiming to assist patient-specific treatment plans by integrating Labcorp’s precision medicine testing with VieCure’s clinical decision-support tool.
January 25, 2023
Thermo Fisher Scientific, AstraZeneca to develop solid tissue and blood-based CDx for NSCLC
The companion diagnostic leverages Thermo Fisher’s Oncomine Dx Express Test on its Genexus Dx System, a fully integrated next-generation sequencing platform, with an automated specimen-to-report workflow that provides results in 24 hours.
January 24, 2023
Thermo Fisher Scientific launches sequencing assay to ID variants that may resist HIV therapies
The assay, which uses HIV RNA extracted from plasma or dried blood spots, is designed to analyze genomic mutations in the protease, reverse transcriptase, and integrase regions of the HIV-1 pol gene across nine subtypes of global significance.
January 24, 2023
Qiagen Digital Insights launches NGS analysis to process whole genome for $1 in cloud computing costs
The product incorporates a software accelerator that quickly converts raw sequencing data in FASTQ files from any paired-end short-read sequencing platform into interpretable lists of genetic variants in the VCF format.
January 23, 2023
DNA sequencing method offers peek into genomic black box
University of Cambridge researchers have outlined a new DNA sequencing method that detects where and how small molecule drugs interact with a targeted genome.
January 23, 2023
Jumpcode Genomics enters PacBio’s Compatible Partner program
Jumpcode’s Single Cell RNA Boost Kit is compatible with PacBio’s Multiplexed Arrays Sequencing (MAS-Seq) for 10x Single Cell 3’ kit, which allows researchers to remove uninformative fragments from single-cell RNA sequencing libraries prior to sequencing.
January 12, 2023
Most Popular
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
Roche reports flat diagnostics revenue growth for 2022
French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M
OIG report outlines challenges with CDC-supported COVID-19 vaccination programs
Element Biosciences debuts high-throughput update to benchtop sequencer
DNA sequencing technology developer Element Biosciences unveiled a new throughput-based option for its Aviti System that provides high-quality sequencing on a benchtop for as low as $200 a genome, or $2 per gigabase.
January 12, 2023
Qiagen, Helix collaborate to market companion diagnostic products for hereditary diseases
Under the agreement, Qiagen will be the exclusive marketing and contracting partner in the U.S. for Helix’s companion diagnostic services.
January 5, 2023
Alercell preparing January launch of sequencing test for leukemia
The Montana-based firm also aims to launch a methylation-based molecular diagnostic test for lung cancer later in the first quarter of 2023.
December 29, 2022
Integrated DNA Technologies acquires Invitae’s Archer NGS research assays for $48M
IDT said that the addition of next-generation sequencing research panels and bioinformatics expands IDT's position as an oncology research solutions provider.
December 20, 2022
Quantum-Si launches next-generation single-molecule sequencing platform
According to the firm, the small footprint and lower price of the new platform are aimed at providing greater accessibility to high-resolution sequencing data.
December 20, 2022
SeekIn announces CE Mark approval for WGS cancer mutation detection test
The PanCanSeek test is ready to launch in the EU and countries in other regions that recognize the CE-IVD Mark, SeekIn said.
December 19, 2022
Page 1 of 40
Next Page
